RWM
EBS icon

Raffa Wealth Management’s Emergent Biosolutions EBS Stock Holding History

Raffa Wealth Management’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-12
Closed -$394 – 508
2016
Q4 		$394 Hold
12
– – ﹤0.01% 826
2016
Q3 		$378 Hold
12
– – ﹤0.01% 811
2016
Q2 		$337 Sell
12
-4
-25% -$157 ﹤0.01% 814
2016
Q1 		$582 Hold
16
– – ﹤0.01% 626
2015
Q4 		$640 Hold
16
– – ﹤0.01% 563
2015
Q3 		$456 Hold
16
– – ﹤0.01% 704
2015
Q2 		$527 Sell
16
-4
-20% -$124 ﹤0.01% 684
2015
Q1 		$575 Hold
20
– – ﹤0.01% 638
2014
Q4 		$545 Hold
20
– – ﹤0.01% 634
2014
Q3 		$426 Buy
+20
New +$458 ﹤0.01% 728
2014
Q1 		– Sell
-20
Closed -$545 – 410
2013
Q4 		$545 Buy
+20
New +$417 ﹤0.01% 634

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
AAM
Aberdeen Asset Management Aberdeen, United Kingdom $30B AUM 22.69% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.79B AUM 33.56% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Raffa Wealth Management's EBS Position: Q1 2017 in Review

Raffa Wealth Management sold out of Emergent Biosolutions (EBS) in Q1 2017, closing a stake of 12 shares — an estimated $394 sold.

Raffa Wealth Management first reported a position in EBS in Q4 2013 and held it in 11 quarters. The position peaked at $640 in Q4 2015. 176 funds tracked by Wall St. Rank hold EBS as of Q1 2017.

  • Raffa Wealth Management reported no remaining Emergent Biosolutions position as of Q1 2017 after selling out during the quarter.
  • Raffa Wealth Management sold 12 Emergent Biosolutions shares in Q1 2017, an estimated $394.
  • Raffa Wealth Management first reported a position in Emergent Biosolutions in Q4 2013 and held it in 11 quarters.
  • Raffa Wealth Management's Emergent Biosolutions position peaked at $640 in Q4 2015.
  • 176 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2017.

Based on Raffa Wealth Management's 13F filing for Q1 2017, filed 27 Jul 2026.